Evidence map›Paper›PMID 33533563›Full record

Observational studyDermatologic therapy2021

COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi-center, real-life, telemedical, and observational prospective study.

Giovanni Damiani, Laura C Gironi, Ayman Grada, Khalaf Kridin, Renata Finelli, Alessandra Buja, Nicola L Bragazzi, Paolo D M Pigatto, Paola Savoia

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Dermatologic therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
24.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Italian Expert Consensus on Clinical and Therapeutic Management of Multiple Chemical Sensitivity (MCS).International journal of environmental research and public health · 2021
    Pooled it
  3. Randomised, split-face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and NeurosensineSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Consumer attitudes toward aging skin during the COVID-19 pandemic.International journal of women's dermatology · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Hi5 Protocol for the Use of Microfocused Ultrasound with Visualization.Plastic and reconstructive surgery. Global open · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Giovanni DamianiClinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.ORCID https://orcid.org/0000-0002-2390-6505
Laura C GironiAOU Maggiore della Carità, Novara, Italy.ORCID https://orcid.org/0000-0002-7298-4446
Ayman GradaDepartment of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-5321-0584
Khalaf KridinLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.ORCID https://orcid.org/0000-0001-9971-9151
Renata FinelliAmerican Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-5926-6407
Alessandra BujaDepartment of Cardiac, Thoracic, Vascular Sciences, and Public Health, Unit of Hygiene and Public Health, University of Padua, Padua, Italy.
Nicola L BragazziDepartment of Mathematics and Statistics, Laboratory for Industrial and Applied Mathematics (LIAM), York University, Toronto, Canada.
Paolo D M PigattoClinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Paola SavoiaDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Padua · ITBoston University · USCleveland Clinic · USUniversity of Lübeck · DEUniversity of Milan · ITYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Masks are essential for COVID-19 prevention, but recently they were suggested to modify cutaneous facial microenvironment and trigger facial dermatoses. To evaluate mask-related rosacea and acne (maskne) in untreated patients during lockdown. In this multi-center, real-life, observational prospective study, we enrolled stable, untreated acne and rosacea patients that wore masks during lockdown at least 6 h/day. They underwent two teledermatological consultations, at the baseline and after 6 weeks. Clinical, pharmacological, and psychological data were recorded. A total 66 patients, 30 (median age: 34.0 [30.25-29.75] yoa) with acne and 36 patients (median age: 48 [43-54] years) with rosacea, were enrolled in this study. After 6 weeks of mask and quarantine, patients with acne displayed an increased Global Acne Grading Scale (GAGS) score in mask-related areas (P < .0001). Likewise, after 6 weeks of mask and quarantine, patients with rosacea displayed a worsen in both physican (P < .0001) and patient (P < .0001) reported outcomes. Remarkably, patients reported also a statistically significant decrease in their quality of life (P < .0001). Masks appear to trigger both acne and rosacea flares. Additional studies are needed to generate evidence and inform clinical decision-making.

Indexed as

Acne VulgarisCOVID-19RosaceaAdultCommunicable Disease ControlHumansMasksMiddle AgedProspective StudiesQuality of LifeSARS-CoV-2acne due to masksCOVID-19masknemask rosaceapandemicsrosacea due to masks

Identifiers

PMID33533563
PMCPMC7995182
OpenAlexW3126992018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.